Patent 10134398
Extensions
Patent term adjustments, term extensions, continuations, divisionals, family members, and expiration dates.
Active provider: Google · gemini-2.5-flash
Extensions
Patent term adjustments, term extensions, continuations, divisionals, family members, and expiration dates.
US Patent 10,134,398 has a priority date of October 9, 2014, and a filing date of November 9, 2016. The patent was issued on November 20, 2018. The standard patent term is 20 years from the earliest filing date (or the earliest claimed priority date if it's a continuation, divisional, or continuation-in-part). Therefore, the anticipated expiration date for US10134398, without any adjustments or extensions, would be October 9, 2034.
Patent Term Adjustments (PTA)
Patent Term Adjustment (PTA) can extend the patent term to compensate for certain administrative delays by the USPTO during the patent examination process. For applications filed on or after May 29, 2000, PTA aims to ensure the patentee receives the full term of protection they are entitled to.
Delays that can lead to PTA include:
- USPTO failing to issue a first office action within 14 months of filing.
- USPTO failing to act on an applicant's response within four months.
- USPTO failing to issue a patent within four months of payment of the issue fee.
- The application pending for more than three years.
- Delays due to interference proceedings, secrecy orders, or successful appeals.
Any PTA granted can be reduced by delays caused by the applicant. The provided information does not specify if any PTA was granted for US10134398. To determine the exact PTA, a review of the patent's prosecution history on the USPTO's Patent Center would be necessary.
Patent Term Extensions (PTE)
Patent Term Extensions (PTE) are separate from PTA and are granted under 35 U.S.C. § 156 for patents claiming certain human drug products, medical devices, animal drugs, or food/color additives. This extension compensates for time lost during the pre-market government approval process by a regulatory agency (e.g., FDA).
Based on the subject matter of US10134398 ("Hotword detection on multiple devices"), it is highly unlikely to be eligible for PTE, as it does not appear to cover products subject to pre-market regulatory review by agencies like the FDA. The provided information does not indicate any PTE for this patent.
Continuation and Divisional Applications
The provided patent abstract and summary indicate that this application is a continuation of U.S. application Ser. No. 15/088,477, filed Apr. 1, 2016, which is a continuation of U.S. application Ser. No. 14/675,932, filed Apr. 1, 2015, which claims the benefit of U.S. Provisional Application Ser. No. 62/061,830, filed on Oct. 9, 2014. These are explicitly mentioned in the "CROSS-REFERENCE TO RELATED APPLICATION" section of the patent.
Continuation Applications:
- U.S. application Ser. No. 15/088,477, filed Apr. 1, 2016.
- U.S. application Ser. No. 14/675,932, filed Apr. 1, 2015.
Divisional Applications: The provided patent text does not explicitly mention any divisional applications. A divisional application is typically filed when an examiner determines an application contains two or more patentable inventions and requires the applicant to elect one.
Related Family Members
Based on the cross-reference to related applications in the patent text, the related family members directly mentioned are the parent applications from which US10134398 claims priority:
- U.S. application Ser. No. 15/088,477
- U.S. application Ser. No. 14/675,932
- U.S. Provisional Application Ser. No. 62/061,830
Additionally, Google's patent family includes other related patents such as US10593330B2, US10909987B2, US11557299B2, US11915706B2, and US12254884B2, as well as publication US20170084277A1.
Projected Expiration Date
The patent term for utility patents filed on or after June 8, 1995, is generally 20 years from the earliest filing date of the application, or the earliest application for which a benefit is claimed under 35 U.S.C. §§ 120, 121, or 365(c).
US10134398 claims benefit to U.S. Provisional Application Ser. No. 62/061,830, filed on October 9, 2014. Therefore, the base expiration date would be 20 years from this priority date.
Base Expiration Date: October 9, 2014 + 20 years = October 9, 2034.
This date is subject to any Patent Term Adjustments (PTA) or terminal disclaimers. Without the specific PTA calculation from the USPTO for this patent, the precise expiration date cannot be definitively determined. However, given the nature of the patent and the lack of mention of pharmaceutical or medical device claims, PTE is not applicable.
Generated 6/10/2026, 12:02:12 AM